title: Primary gastric plasmacytoma associated with Helicobacter pylori infection: a report of two cases with different prognosis.
abstract: We describe two cases of primary gastric plasmacytoma (GP) associated with Helicobacter pylori infection. Case 1 was that of a 58-year-old man with epigastric pain. H. pylori was eradicated before surgical resection was performed, and after the therapy, the tumor size was reduced. A postoperative pathological examination revealed that the tumor was in early stage and histological grade was grade 1. After 44 months of operation, the patient was in complete remission with no evidence of local relapse or progression to systemic MM. Case 2 was that of a 70-year-old woman with a history of melena. H. pylori eradication was not presented preoperatively. The resected specimen showed the tumor was in advanced stage and histological grade 3. GP eventually progressed to MM and she died of pulmonary infection. In our opinion, GP cannot be eradicated with H. pylori eradication, but disease progression can be effectively controlled to a certain extent. The prognosis of this disease is relatively fair when treated at an early stage. In addition to the treatment, the difference in prognosis could be associated with age, the stage of the tumor, and histological grade.
authors.affiliation: Taizhou Central Hospital of Taizhou Enze Medical Group, Taizhou, China. luhongsheng00@163.com
authors.forename: Hong-sheng
authors.initials: HS
authors.lastname: Lu
authors.forename: Yun-feng
authors.initials: YF
authors.lastname: Xu
authors.forename: Mei-fu
authors.initials: MF
authors.lastname: Gan
mesh_terms: D000368:Aged; D017809:Fatal Outcome; D005260:Female; D016481:Helicobacter Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010954:Plasmacytoma / Q000382:microbiology / Q000601:surgery*; D011379:Prognosis; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000382:microbiology / Q000601:surgery*; D016896:Treatment Outcome
references.citation: World J Gastroenterol. 2008 Apr 21;14(15):2388-93
references.pmid: 18416467
references.citation: J Clin Oncol. 2009 Jan 1;27(1):150-3
references.pmid: 19047299
references.citation: Ann Hematol. 2004 Oct;83(10):666
references.pmid: 15449033
references.citation: Leukemia. 2009 Jan;23(1):3-9
references.pmid: 18971951
references.citation: J Gastroenterol. 2002;37(5):398-401
references.pmid: 12051542
references.citation: J Clin Oncol. 2002 Jan 1;20(1):344-7
references.pmid: 11773190
references.citation: Gastrointest Endosc. 2001 Mar;53(3):352-5
references.pmid: 11231401
references.citation: Nihon Shokakibyo Gakkai Zasshi. 2005 Jun;102(6):687-92
references.pmid: 15981625
references.citation: Intern Med. 2003 Apr;42(4):370-2
references.pmid: 12729330
references.citation: Ann Hematol. 2003 Sep;82(9):589-92
references.pmid: 12898183
references.citation: J Clin Gastroenterol. 2005 Jan;39(1):56-7
references.pmid: 15599212
references.citation: Br J Cancer. 1997;75(6):921-7
references.pmid: 9062417
references.citation: AJR Am J Roentgenol. 1999 Nov;173(5):1266-8
references.pmid: 10541102
references.citation: Gastroenterol Hepatol. 2008 Apr;31(4):217-20
references.pmid: 18405486
references.citation: Acta Gastroenterol Latinoam. 1999;29(3):119-23
references.pmid: 10533659